within Pharmacolibrary.Drugs.ATC.D;

model D10AD53
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.01,
    Cl             = 0.0016666666666666668,
    adminDuration  = 600,
    adminMass      = 0.002,
    adminCount     = 1,
    Vd             = 0.005,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Adapalene, in combination with benzoyl peroxide (as in ATC code D10AD53), is a topical retinoid used primarily for the treatment of acne vulgaris. The combination enhances comedolytic, anti-inflammatory, and antibacterial effects. This product is approved for clinical use in several countries.</p><h4>Pharmacokinetics</h4><p>Estimated pharmacokinetic model for healthy adults using topical gel formulation of adapalene 0.1% with benzoyl peroxide 2.5%; limited systemic absorption expected in healthy skin.</p><h4>References</h4><ol><li><p>Piérard, GE, et al., &amp; Quatresooz, P (2009). Spotlight on adapalene. <i>Expert opinion on drug metabolism &amp; toxicology</i> 5(12) 1565–1575. DOI:<a href=&quot;https://doi.org/10.1517/17425250903386269&quot;>10.1517/17425250903386269</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/19929446/&quot;>https://pubmed.ncbi.nlm.nih.gov/19929446</a></p></li><li><p>Najafi-Taher, R, et al., &amp; Amani, A (2018). Delivery of adapalene using a novel topical gel based on tea tree oil nano-emulsion: Permeation, antibacterial and safety assessments. <i>European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences</i> 120 142–151. DOI:<a href=&quot;https://doi.org/10.1016/j.ejps.2018.04.029&quot;>10.1016/j.ejps.2018.04.029</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/29684425/&quot;>https://pubmed.ncbi.nlm.nih.gov/29684425</a></p></li><li><p>van Hoogdalem, EJ (1998). Transdermal absorption of topical anti-acne agents in man; review of clinical pharmacokinetic data. <i>Journal of the European Academy of Dermatology and Venereology : JEADV</i> 11 Suppl 1 S13–S29. DOI:<a href=&quot;https://doi.org/10.1111/j.1468-3083.1998.tb00902.x&quot;>10.1111/j.1468-3083.1998.tb00902.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/9891904/&quot;>https://pubmed.ncbi.nlm.nih.gov/9891904</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end D10AD53;
